Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies

International Journal of Urology

Volumn 12, Issue 11, 2005, Pages 964-968

  Miyake, Hideaki ^a   Kurahashi, Toshifumi ^b   Muramaki, Mototsugu ^b   Yamanak, Kazuki ^b   Hara, Isao ^b  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Prostate cancer; Radical prostatectomy; Transition zone; Transrectal biopsy

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SPINAL CORD; TRANSRECTAL ULTRASONOGRAPHY;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 30944456474     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2005.01188.x     Document Type: Article

References (29)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided tranrectal core biopsies of the prostate. J. Urol. 1989; 142: 71-5.
2. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50: 562-6.
3. Babaian RJ, Toi A, Kamoi K et al. A comparatively analysis of sextant and an extended 11-core multisite directed biopsy strategy. J. Urol. 2000; 163: 152-7.
4. Presti JC Jr, Chang JJ, Bhargava V et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J. Urol. 2000; 163: 163-7.
5. Gore JL, Shariat SF, Miles BJ et al. Optimal combination of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J. Urol. 2001; 165: 1554-9.
6. Ishimura T, Sakai I, Kara I, Eto H, Miyake H. Clinical outcome of transrectal ultrasound guided prostate biopsy targeting eight cores for detecting prostate cancer in Japanese men. Int. J. Clin. Oncol. 2004; 9: 47-50.
7. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am. J. Surg. Pathol. 1988; 12: 897-906.
8. Fink KG, Hutarew G, Esterbauer B et al. Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy. Urology 2003; 61: 748-53.
9. Keetch DW, Catalona WJ. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. J. Urol. 1995; 154: 1795-7.
10. Fleshner NE, Fair WR. Indications for transition zone biopsy in the detection of prostatic carcinoma. J. Urol. 1997; 157: 556-8.
11. Liu IJ, Macy M, Lai YH, Terris MK. Critical evaluation of the current indications for transition zone biopsies. Urology 2001; 57: 1117-20.
12. Lui PD, Terris MK, McNeal JE, Stamey TA. Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J. Urol. 1995; 153: 1000-1003.
13. Park SJ, Miyake H, Hara I, Eto H. Predictors of prostate cancer on repeat tranrectal ultrasound-guided systematic prostate biopsy. Int. J. Urol. 2003; 10: 68-71.
14. Bazinet M, Karakiewicz PI, Aprikian AG et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J. Urol. 1996; 155: 605-606.
15. Kojima Y, Nonomura N, Nose T et al. Transition zone biopsy in the detection of prostate cancer. Eur. Urol. 2000; 37: 675-9.
16. Morote J, Lopez M, Encabo G, de Torres I. Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time. Eur. Urol. 1999; 35: 294-7.
17. Onder AU, Yalcin V, Arar O, Yaycioglu O, Citci A, Solok V. Impact of transition zone biopsies in detection and evaluation of prostate cancer. Eur. Urol. 1998; 33: 542-8.
18. Terris MK, Pham TQ, Issa MM, Kabalin JN. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J. Urol. 1997; 157: 204-206.
19. Miyake H, Sakai I, Ishimura T, Hara I, Eto H. Significance of cancer detection in the anterior lateral horn on systematic prostate biopsy: impact on pathological findings of radical prostatectomy specimens. BJU Int. 2004; 93: 53-9.
20. Egawa S, Koh H, Satoh T et al. Preoperative serum prostate-specific antigen, clinical stage and Gleason sum as basis for predicting final pathological stage in Japanese prostate cancer. Jpn J. Clin. Oncol. 1996; 26: 438-4.
21. Grossklaus DJ, Coffey CS, Shappell SB, Jack GS, Chang SS, Cookson MS. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J. Urol. 2002; 167: 2032-5.
22. International Union Against Cancer. TNM Classification of Malignant Tumors, 5th edn. John Wiley & Sons, New York, 1997; 170-3.
23. Naughton CK, Miller DC, Mager DE et al. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J. Urol. 2000; 164: 388-92.
24. Oestering JE, Kumamoto Y, Tsukamoto T et al. Serum prostatic-specific antigen in a community-based population of healthy Japanese men; lower values than for similarly aged white men. Br. J. Urol. 1995; 75: 347-53.
25. Sebo TJ, Bock BJ, Cheville JC et al. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and Volume at radical prostatectomy. J. Urol. 2000; 163: 174-8.
26. Veltri RW, Miller MC, Partin AW et al. Prediction of prostate carcinoma stage by quantitative biopsy pathology. Cancer 2001; 91: 2322-8.
27. Onder AU, Yaycioglu O, Ataus S et al. Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy. Int. J. Urol. 2003; 10: 302-306.
28. Noguchi M, Stamey TA, McNeal JE, Yemoto CE. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J. Urol. 2000; 163: 1751-5.
29. Augustin H, Erbersdobler A, Graefen M et al. Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones. Prostate 2003; 55: 48-54.